SCHEMBL7116802

SCHEMBL7116802

CC(NC#N)c1ccccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
GAA P10253 1/20 0.42
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 2/20 0.41
SLC6A3 Q01959 1/20 0.41
TSHR P16473 1/20 0.41
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
EGFR P00533 1/20 0.39
KCNA5 P22460 5/20 0.39
KCNH2 Q12809 1/20 0.39
NPSR1 Q6W5P4 2/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537851 0.81 CYP1A2 (0.42) MEN1KMT2ASMN1; SMN2GAASLC6A2
SCHEMBL5349302 0.78 SLC6A2 (0.48) MEN1KMT2AGAASLC6A2SLC6A4
SCHEMBL12310369 0.76 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3TSHRALDH1A1
SCHEMBL13081517 0.76 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3TSHRALDH1A1
SCHEMBL125581 0.76 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3TSHRALDH1A1
SCHEMBL12259279 0.75 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3TSHRALDH1A1
SCHEMBL21884123 0.75 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3TSHRALDH1A1
SCHEMBL22275828 0.75 SMN1; SMN2 (0.49) MEN1KMT2ASMN1; SMN2GAASLC6A2
SCHEMBL18513568 0.75 SLC6A2 (0.45) MEN1KMT2AGAASLC6A2SLC6A4
SCHEMBL13075728 0.75 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040116418-A1 Compounds and methods for inhibition of HIV and related viruses MEDIVIR AB (SE) 2004-06-17 US disclosed
US-6376492-B1 GUANIDINE DERIVATIVES MEDIVIR AB (SE) 2002-04-23 US disclosed
US-5849769-A N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection MEDIVIR AB (SE) 1998-12-15 US disclosed
EP-0706514-B1 COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES MEDIVIR AB (SE) 1998-11-18 EP disclosed
EP-0706514-A1 COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES MEDIVIR AB (SE) 1996-04-17 EP disclosed
WO-1995006034-A1 COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES MEDIVIR AB (SE) 1995-03-02 WO disclosed